ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

American College of Cardiology

Episodes 100
Avg. Duration 12m
Activity Highly Active
Since Aug 2024
Latest Episode Jun 2026

Publishing Details

Schedule
Weekly
Format
Episodic
Consistency
100%
Hosting
accelaccorg.libsyn.com

Contact & Outreach

About This Podcast

The American College of Cardiology offers select interviews and summaries of cardiology's most interesting research areas from ACCEL's renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.

Explore Statistics

Recent Episodes

Key Take-Home Messages From the 2025 Sports Cardiology Guidelines

Jun 09, 2026 11m

There is increasing emphasis on shared decision-making when evaluating sports participation for competitive athletes with cardiovascular disease, reflecting a shift toward more individualized care.…

Insights From the CADENCE Trial

Jun 02, 2026 12m

In the CADENCE proof-of-concept study, sotatercept demonstrated meaningful improvements in pulmonary vascular and cardiac hemodynamics in patients with combined pre‑ and post‑capillary pulmonary…

A Look At The ORBITA-CTO Trial

May 26, 2026 12m

The ORBITA-CTO trial was a multicenter, randomized, double-blinded study that enrolled 50 patients with symptomatic single-vessel chronic total occlusion (CTO) and no bystander coronary disease.…

THRIVE Food is Medicine Pilot Trial: Addressing Hypertension Through Produce Prescriptions

May 19, 2026 16m

The American Heart Association–funded THRIVE Food is Medicine pilot trial demonstrated strong promise in addressing hypertension through produce prescriptions. Participants in the intervention arm…

Inflammation in CVD: A 2025 ACC Scientific Statement

May 12, 2026 10m

Inflammation has emerged as a critical contributor to the pathogenesis and clinical outcomes of cardiovascular disease (CVD), with growing evidence highlighting the prognostic relevance of residual…

Lower LDL-C for Longer? Defining the Optimal Timing and Intensity of Rx

May 05, 2026 11m

Should statin therapy be routinely initiated in middle‑aged adults with at least one atherosclerotic cardiovascular disease risk factor and LDL‑C levels above 100 mg/dL? Observational data…

Keeping it Simple: Top 10 Things to Know About the 2026 Dyslipidemia Guideline

Apr 28, 2026 12m

The 2026 ACC/AHA Dyslipidemia Guidelines highlight that Lp(a) confers a graded ASCVD risk, with levels around 125 nmol/L (50 mg/dL) indicating meaningful risk and ~250 nmol/L (100 mg/dL) identifying…

Heart and Liver Health: Interconnectedness of CV and Hepatic Risk

Apr 21, 2026 10m

ardiac and hepatic function are closely interconnected, with deterioration in one organ often accelerating disease progression in the other. Emerging evidence, including data suggesting semaglutide…

Addressing Cardiovascular-Kidney-Metabolic Syndrome Health

Apr 14, 2026 14m

Cardiovascular-Kidney-Metabolic (CKM) syndrome encompasses a spectrum of interconnected cardiovascular, kidney, and metabolic conditions that progress through defined stages. A five-stage CKM…

Sotatercept: New Therapies for PAH

Apr 07, 2026 11m

Pulmonary arterial hypertension (PAH) remains a devastating, progressive disease with high morbidity and mortality despite advances in targeted therapies. Sotatercept, the most recent addition to the…

Does Eliminating Coffee Avoid Fibrillation (DECAF) Trial

Mar 31, 2026 11m

Caffeinated coffee may reduce the risk of atrial fibrillation through several proposed mechanisms, including improved autonomic balance, antioxidant effects, and enhanced vascular function. While…

Evaluating the 2025 AHA/ACC High Blood Pressure Guideline

Mar 24, 2026 13m

The 2025 High Blood Pressure Guideline introduces key updates to the 2017 recommendations, reflecting the evolving understanding of hypertension and its long‑term impact on patient health. This…

Cardiovascular-Kidney Therapies in CKD

Mar 17, 2026 12m

Heart and kidney disease are closely linked, as individuals with chronic kidney disease (CKD) face a significantly higher risk of cardiovascular events and heart failure. Because this cardiometabolic…

Prasugrel Benefits Patients With Diabetes and Multivessel Disease Post-PCI: TUXEDO-2 Trial

Mar 10, 2026 12m

The findings from the TUXEDO‑2 trial provide important clinical insights for managing high‑risk patients with diabetes and multivessel coronary disease undergoing stenting. By directly comparing…

The Power of Nutrition: GOFRESH Trial

Mar 03, 2026 12m

The GOFRESH trial showed that providing DASH‑patterned groceries through a structured grocery‑ordering strategy meaningfully lowered systolic blood pressure and LDL cholesterol among Black families…

OCEAN Trial: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation

Feb 24, 2026 14m

The OCEAN Trial found that rivaroxaban did not significantly reduce the incidence of stroke, systemic embolism, or new covert embolic events compared with aspirin in patients at high risk for stroke…

NOTIFY-PICTURE Trial: Real-Time Notification of AI-Derived Incidental CAC on Statin Initiation

Feb 17, 2026 9m

What exactly is incidental coronary artery calcification, and what does it mean when artificial intelligence identifies these calcifications? Incidental coronary artery calcification refers to…

VESALIUS-CV Trial: Effect of Evolocumab in Patients at CV Risk without Prior MI or Stroke

Feb 10, 2026 9m

The VESALIUS‑CV trial demonstrated that adding the PCSK9 inhibitor evolocumab to optimized lipid‑lowering therapy significantly reduced the risk of first major cardiovascular events by 25% in…

ACCEL Lite: Hypertension Treatment Trials in the Elderly for Brain Health

Feb 03, 2026 12m

Is the evidence convincing that intensive antihypertensive therapy protects brain function and helps prevent dementia? Research increasingly shows that high mid‑life blood pressure is a strong…

ACCEL Lite: SURPASS-CVOT: Effect of Tirzepatide Versus Dulaglutide on MACE

Jan 27, 2026 12m

In patients with Type 2 diabetes and established atherosclerotic cardiovascular disease (ASCVD), tirzepatide was non‑inferior to dulaglutide for major cardiovascular events while providing superior…

Frequently Asked Questions

How many episodes does ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research have?

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research has published 100 episodes since August 2024, covering topics in Education, Health & Fitness.

Is ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research still active?

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research is currently highly active with new episodes weekly. Average episode length is 12m.

How do I contact ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research for sponsorship or guest appearances?

Sign up on Grep.FM to access contact details for ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research, including email and social media links.

Similar Podcasts